| Title | Author(s) | Year | View Count |
 | Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine | Sandhya, V; Schlesinger, SJ; Chen, Z; Hurley, A; Lombardo, A; Than, S; Adesanya, P; Bunce, C; Boaz, M; Boyle, R; Sayeed, E; Clark, L; Dugin, D; Boente-Carrera, M; Schmidt, C; Fang, Q; LeiBa,; Huang, Y; Zaharatos, GJ; Gardiner, DF; Caskey, M; Seamons, L; Ho, M; Dally, L; Smith, C; Cox, J; Gill, D; Gilmour, J; Keefer, MC; Fast, P; Ho, DD | 2010 | 190 |
| Phase I safety and immunogenicity evaluation of ADVAX, a Multigenic, DNA-based Clade C/B' HIV-1 candidate vaccine | Vasan, S; Schlesinger, SJ; Huang, Y; Hurley, A; Lombardo, A; Chen, Z; Than, S; Adesanya, P; Bunce, C; Boaz, M; Boyle, R; Sayeed, E; Clark, L; Dugin, D; Schmidt, C; Song, Y; Seamons, L; Dally, L; Ho, M; Smith, C; Markowitz, M; Cox, J; Gill, DK; Gilmour, J; Keefer, MC; Fast, P; Ho, DD | 2010 | 184 |
|
